The E3 ubiquitin ligase RNF135 regulates the tumorigenesis activity of tongue cancer SCC25 cells

Cancer Medicine

Volumn 5, Issue 11, 2016, Pages 3140-3146

  Jin, Jian ^a   Zhao, liya ^a   Li, Zubing ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Cell proliferation; E3 ubiquitin ligase; invasion; RNF135; SCC25 cell

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE E3 RNF135; UNCLASSIFIED DRUG; PROTEIN BINDING; PROTEIN KINASE B; PTEN PROTEIN, HUMAN; RNF135 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL LINE; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCC25 CELL LINE; TONGUE CANCER; TUMOR XENOGRAFT; ANIMAL; CELL SURVIVAL; CELL TRANSFORMATION; DISEASE MODEL; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; SIGNAL TRANSDUCTION; TONGUE TUMOR; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HETEROGRAFTS; HUMANS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TONGUE NEOPLASMS; UBIQUITIN-PROTEIN LIGASES;

EID: 84990829182     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.832     Document Type: Article

References (15)

1. Siegel, R., E. Ward, O. Brawley, and A. Jemal. 2011. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 61:212–236.
2. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425–479.
3. Malynn, B. A., and A. Ma. 2010. Ubiquitin makes its mark on immune regulation. Immunity 33:843–852.
4. Zeng, T., Q. Wang, J. Fu, Q. Lin, J. Bi, W. Ding, et al. 2014. Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis. Cell Rep. 7:871–882.
5. Mei, Z., D. Zhang, B. Hu, J. Wang, X. Shen, and W. Xiao. 2015. FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity. J. Biol. Chem. 290:16202–16214.
6. Wang, L., X. Wang, Y. Zhao, W. Niu, G. Ma, W. Yin, et al. 2016 May 26. E3 Ubiquitin ligase RNF126 regulates the progression of tongue cancer. Cancer Med. doi:10.1002/cam4.771.
7. Zhou, M. J., F. Z. Chen, and H. C. Chen. 2014. Ubiquitination involved enzymes and cancer. Med. Oncol. 31:93.
8. Lippman, S. M., J. Sudbo, and W. K. Hong. 2005. Oral cancer prevention and the evolution of molecular-targeted drug development. J. Clin. Oncol. 23:346–356.
9. Lynch, T. J., D. W. Bell, R. Sordella, S. Gurubhagavatula, R. A. Okimoto, B. W. Brannigan, et al. 2004. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 350:2129–2139.
10. Kwak, E. L., Y. J. Bang, D. R. Camidge, A. T. Shaw, B. Solomon, R. G. Maki, et al. 2010. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 363:1693–1703.
11. Tang, X. H., A. M. Urvalek, K. Osei-Sarfo, T. Zhang, T. Scognamiglio, and L. J. Gudas. 2015. Gene expression profiling signatures for the diagnosis and prevention of oral cavity carcinogenesis-genome-wide analysis using RNA-seq technology. Oncotarget 6:24424–24435.
12. Komander, D., and M. Rape. 2012. The ubiquitin code. Annu. Rev. Biochem. 81:203–229.
13. Ye, Y., and M. Rape. 2009. Building ubiquitin chains: E2 enzymes at work. Nat. Rev. Mol. Cell Biol. 10:755–764.
14. Kim, H. C., and J. M. Huibregtse. 2009. Polyubiquitination by HECT E3s and the determinants of chain type specificity. Mol. Cell. Biol. 29:3307–3318.
15. Huang, L., E. Kinnucan, G. Wang, S. Beaudenon, P. M. Howley, J. M. Huibregtse, et al. 1999. Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science 286:1321–1326.